Bellerophon Ther Com (NQ: BLPH )

9.650 USD +0.330 (+3.54%)

Official Closing Price Updated: 4:48 PM EDT, Sep 25, 2020 Add to My Watchlist

Price and Volume

Volume	24,500
Open	9.470
Bid (Size)	6.310 (1)
Ask (Size)	11.87 (1)
Prev. Close	9.320
Today's Range	9.180 - 9.760
52wk Range	0.2700 - 26.00
Shares Outstanding	57,468,175
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Bellerophon to Present at Two September Investor Conferences

September 14, 2020

Bellerophon Appoints Cardiopulmonary Disease Expert Wassim Fares, M.D., MSCR, as Chief Medical Officer

August 11, 2020

Performance

YTD	+2657.14%	+2657.14%
1 Month	-14.53%	-14.53%
3 Month	-25.54%	-25.54%
6 Month	-21.54%	-21.54%
1 Year	+1910.42%	+1910.42%

More News

Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results

August 05, 2020

Bellerophon Therapeutics Announces Publication of Cohort 1 of iNO-PF Phase 2/3 Study in the CHEST Journal and Participation in Webinar to Discuss Clinical Results

July 15, 2020

Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19

July 13, 2020

Bellerophon Therapeutics Added to Russell 3000® and Microcap® Indexes

June 29, 2020

Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares

May 22, 2020

Insider Buys Bellerophon Therapeutics Shares

September 14, 2020

Bellerophon Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Registered Direct Offering

May 19, 2020

The Math Shows IWO Can Go To $258

August 12, 2020

Protalix BioTherapeutics Pipeline Progress

July 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.